BOSTON, Sept. 27, 2017 /PRNewswire/ -- Replikins, LLC., a Boston-based biotechnology research and analytics firm, today introduced the first weekly subscription service that can predict the onset of a viral outbreak. Replikins Gene Surveillance™ was developed after 10 years of successful global predictive trials by the company on influenza H1N1, H2N3, H5N1, H7N9, Mers-CoV, Ebola, Zika, and other viruses.
This automated quantitative service has successfully predicted specific virus outbreaks, including their cessation, location, and mutation rates. The Figure shows an example. Preventive efforts can now begin before the actual outbreak.
The subscription rates per year for weekly Replikins Gene Surveillance™ are proportional to the number of specimens in the database at the beginning of each annual subscription for each virus requested.
For more information, please contact:
Samuel Bogoch, MD, PhD
References: 1. Bogoch,S 1st Intnl. Zika Conference, Washington, D.C. February 23, 2017. Slides upon request. 2. Kristi Rosa. Readiness is All: Replikins Give Advance Warning of Zika Outbreaks. Infectious Diseases today. Contagion Live . February 27,2017.
View original content with multimedia:http://www.prnewswire.com/news-releases/first-weekly-subscription-service-to-provide-early-warning-of-coming-viral-outbreaks-300526874.html
SOURCE Replikins, LLC